{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:47:37Z","timestamp":1759942057986},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Quadrivalent meningococcal conjugate vaccine is recommended for children, adolescents and adults at increased risk of meningococcal disease. In 2011, MenACWY-CRM (Menveo, GSK, Siena, Italy) was approved for children 2\u201310 years of age in the United States. Although no safety concerns arose from clinical trials, it remains important to monitor its safety in routine clinical settings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Kaiser Permanente Southern California members 2\u201310 years old who received MenACWY-CRM between September 2011 and September 2014 were included. Electronic health records were searched using a validated algorithm to identify 26 prespecified events of interests (EOIs) and serious medically attended events (SMAEs) from inpatient or emergency settings up to 1 year after MenACWY-CRM vaccination. SMAEs were categorized by International Classification of Diseases, 9th revision diagnostic categories. All events were reviewed to confirm the diagnosis and symptom onset date. The study was descriptive (NCT01452438); no statistical tests were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Among 387 vaccinated children, 327 with \u22656 months membership before vaccination were analyzed. Among EOIs, 9 asthma cases and 1 myasthenia gravis case underwent chart review which confirmed 1 incident asthma case occurring 237 days after concomitant vaccination with MenACWY-CRM and typhoid vaccine. Thirty-one children experienced SMAEs, most commonly because of unrelated injury and poisoning. The remaining events occurred sporadically after vaccination and most were unlikely related to vaccination based on medical record review.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>One incident EOI of asthma late in the 1-year observation period and sporadic distribution of SMAEs were observed. These data do not suggest safety concerns associated with MenACWY-CRM vaccination in children 2\u201310 years old.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000001696","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T17:23:33Z","timestamp":1500398613000},"page":"1087-1092","source":"Crossref","is-referenced-by-count":9,"title":["Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2\u201310 Years"],"prefix":"10.1097","volume":"36","author":[{"given":"Sara Yee","family":"Tartof","sequence":"first","affiliation":[{"name":"GSK, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina S.","family":"Sy","sequence":"additional","affiliation":[{"name":"GSK, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley K.","family":"Ackerson","sequence":"additional","affiliation":[{"name":"GSK, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rulin C.","family":"Hechter","sequence":"additional","affiliation":[{"name":"GSK, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mendel","family":"Haag","sequence":"additional","affiliation":[{"name":"GSK, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Slezak","sequence":"additional","affiliation":[{"name":"GSK, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[{"name":"GSK, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine A.","family":"Fischetti","sequence":"additional","affiliation":[{"name":"GSK, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harp S.","family":"Takhar","sequence":"additional","affiliation":[{"name":"GSK, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Miao","sequence":"additional","affiliation":[{"name":"GSK, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zendi","family":"Solano","sequence":"additional","affiliation":[{"name":"GSK, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Jacobsen","sequence":"additional","affiliation":[{"name":"GSK, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Fu","family":"Tseng","sequence":"additional","affiliation":[{"name":"GSK, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230912","first-page":"72","article-title":"Updated recommendations for use of meningococcal conjugate vaccines \u2014 Advisory Committee on Immunization Practices (ACIP), 2010.","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1016\/j.vaccine.2010.09.092","article-title":"Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age.","volume":"28","author":"Halperin","year":"2010","journal-title":"Vaccine"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7812\/TPP\/12-031","article-title":"Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data.","volume":"16","author":"Koebnick","year":"2012","journal-title":"Perm J"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/jama.1994.03520080034035","article-title":"Pertussis vaccination and asthma: is there a link?","volume":"272","author":"Odent","year":"1994","journal-title":"JAMA"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00001648-199711000-00015","article-title":"Is infant immunization a risk factor for childhood asthma or allergy?","volume":"8","author":"Kemp","year":"1997","journal-title":"Epidemiology"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1542\/peds.111.3.653","article-title":"Addressing parents\u2019 concerns: do vaccines cause allergic or autoimmune diseases?","volume":"111","author":"Offit","year":"2003","journal-title":"Pediatrics"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1016\/j.vaccine.2004.02.033","article-title":"No epidemiological evidence for infant vaccinations to cause allergic disease.","volume":"22","author":"Koppen","year":"2004","journal-title":"Vaccine"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1586\/14760584.5.5.631","article-title":"Do vaccines modify the prevalence of asthma and allergies?","volume":"5","author":"S\u00e1nchez-Solis","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1399-3038.2004.00192.x","article-title":"Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren.","volume":"15","author":"Roost","year":"2004","journal-title":"Pediatr Allergy Immunol"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.vaccine.2005.10.056","article-title":"Diphtheria tetanus pertussis poliomyelitis vaccination and reported atopic disorders in 8-12-year-old children.","volume":"24","author":"Bernsen","year":"2006","journal-title":"Vaccine"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ppul.20397","article-title":"Haemophilus influenzae type b vaccination and reported atopic disorders in 8-12-year-old children.","volume":"41","author":"Bernsen","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"e1269","DOI":"10.1542\/peds.2006-3569","article-title":"Is childhood vaccination associated with asthma? A meta-analysis of observational studies.","volume":"120","author":"Balicer","year":"2007","journal-title":"Pediatrics"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.vaccine.2013.03.040","article-title":"Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children.","volume":"31","author":"Tseng","year":"2013","journal-title":"Vaccine"},{"key":"R15-20230912","first-page":"1","article-title":"Injury episodes and circumstances: National Health Interview Survey, 1997\u20132007. National Center for Health Statistics.","volume":";10","author":"Chen","year":"2009","journal-title":"Vital Health Stat"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1542\/peds.109.4.559","article-title":"Epidemiology of pediatric injury-related primary care office visits in the United States.","volume":"109","author":"Hambidge","year":"2002","journal-title":"Pediatrics"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201711000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:12:36Z","timestamp":1694556756000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201711000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001696","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}